These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24573216)

  • 61. Formation of phospholipase C and theta-haemolysin in pre-reduced media in batch anc continuous culture of Clostridium perfringens type A.
    Nord CE; Möllby R; Smyth C; Wadström T
    J Gen Microbiol; 1974 Sep; 84(1):117-27. PubMed ID: 4373522
    [No Abstract]   [Full Text] [Related]  

  • 62. Optimization of the Production of Inactivated Clostridium novyi Type B Vaccine Using Computational Intelligence Techniques.
    Aquino PL; Fonseca FS; Mozzer OD; Giordano RC; Sousa R
    Appl Biochem Biotechnol; 2016 Jul; 179(5):895-909. PubMed ID: 27003282
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clostridium perfringens type A toxin production in 3 commonly used culture media.
    Fernandez-Miyakawa ME; Marcellino R; Uzal FA
    J Vet Diagn Invest; 2007 Mar; 19(2):184-6. PubMed ID: 17402614
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Analysis and improvement of culture processes of pathogenic microorganisms].
    Zaporozhtsev LN
    Zh Mikrobiol Epidemiol Immunobiol; 1981; (8):19-25. PubMed ID: 6274109
    [No Abstract]   [Full Text] [Related]  

  • 65. Effect of peptidic groups isolated from enzymic casein hydrolysate on growth and toxinogenesis of Clostridium welchii (perfringens).
    Nekvasilová K; Sídlo J; Háza J
    J Gen Microbiol; 1970 Jul; 62(1):3-16. PubMed ID: 4321096
    [No Abstract]   [Full Text] [Related]  

  • 66. Production of alpha toxin of Clostridium perfringens. I. Preparation of the reproducible peptone medium for the production of the toxin of high potency.
    KAMEYAMA S; MURATA R; YAMADA T
    Jpn J Med Sci Biol; 1956 Jun; 9(3):81-91. PubMed ID: 13376194
    [No Abstract]   [Full Text] [Related]  

  • 67. [Biologic-economic study of processes for cultivating Clostridium perfringens. II. Comparison of the effectiveness of actual and predicted processes for cultivating microorganisms].
    Zaporozhtsev LN; Basnak'ian IA; Il'nitskaia EA; Vlasenko AP; Artem'eva TA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Oct; (10):37-43. PubMed ID: 200039
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The use of a cell immobilization technic for the continuous cultivation of toxin-forming anaerobes].
    Telishevskaia LIa
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):21-2. PubMed ID: 8553730
    [No Abstract]   [Full Text] [Related]  

  • 69. [Biological-economic study of the Clostridium perfringens cultivation processes. 1. Value of the phasic portrait in the prognosis of the processes of microbial cultivation].
    Basnak'ian IA; Zaporozhtsev LN; Gruntovich VS; Mel'nikova VA; Krylov IuM
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Sep; (9):12-6. PubMed ID: 202118
    [No Abstract]   [Full Text] [Related]  

  • 70. Development of a minimal medium for Clostridium perfringens by using an anaerobic chemostat.
    Goldner SB; Solberg M; Post LS
    Appl Environ Microbiol; 1985 Aug; 50(2):202-6. PubMed ID: 2864896
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Alteration of fermentation products from butyrate to acetate by nitrate reduction in Clostridium perfringens.
    Ishimoto M; Umeyama M; Chiba S
    Z Allg Mikrobiol; 1974; 14(2):115-21. PubMed ID: 4365497
    [No Abstract]   [Full Text] [Related]  

  • 72. Observations on toxin and hemagglutinin produced by Clostridium botulinum type C.
    Oguma K; Nakane A; Iida H
    Appl Environ Microbiol; 1978 Feb; 35(2):462-4. PubMed ID: 205174
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Patterns in the development of deep cultures of Cl. perfringens].
    Akhundova KA; Nenashev VP; Artemenko VD
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Dec; 47(12):29-34. PubMed ID: 4324430
    [No Abstract]   [Full Text] [Related]  

  • 74. Production of Clostridium difficile toxin in a medium totally free of both animal and dairy proteins or digests.
    Fang A; Gerson DF; Demain AL
    Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13225-9. PubMed ID: 19651616
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Use of membrane separation methods in the production of Clostridium perfringens toxoid].
    Semenova VD; Nikolaeva AM; Efimova NP
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (2):32-6. PubMed ID: 9662794
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Influence of water activity on the growth of Clostridium perfringens.
    Strong DH; Foster EF; Duncan CL
    Appl Microbiol; 1970 Jun; 19(6):980-7. PubMed ID: 4318452
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of zinc and calcium ions on the production of alpha-toxin and proteases by Clostridium perfringens.
    Sato H; Yamakawa Y; Ito A; Murata R
    Infect Immun; 1978 May; 20(2):325-33. PubMed ID: 208976
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Dry medium for isolating Clostridium perfringens].
    Gorbushina SN; Kaplunova OP
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Apr; (4):43-6. PubMed ID: 6282016
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Improvement in the Growth and α-toxin Production of Clostridium septicum by Magnesium Sulfate.
    Fathi Najaf M; Hemmaty M; Navidmehr J; Afsharian M; Farhoodi M; Zibaee S
    Arch Razi Inst; 2020 Jun; 75(2):219-225. PubMed ID: 32621451
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Dynamics of changes in the oxidation-reduction potential (rH2) and morphology of Cl. perfringens cultures in the course of toxin formation on semisynthetic culture medium].
    Samsonova VS; Volkova ZM; Shamraeva SA; Tsurikov FF; Solov'ev NN
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Apr; 42(4):137-41. PubMed ID: 4287673
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.